Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis

• Published in: Trends in pharmacological sciences (Regular ed.) Vol. 38; no. 3; pp. 202 - 225
• Main Authors: Wegner, Kelby W, Saleh, Danish, Degterev, Alexei
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-03-2017
• Subjects: Advanced Basic Science; Animals; Humans; Necrosis - enzymology; Receptor-Interacting Protein Serine-Threonine Kinases - metabolism
• ISSN: 0165-6147; 1873-3735
• DOI: 10.1016/j.tips.2016.12.005

A process of regulated necrosis, termed necroptosis, has been recognized as a major contributor to cell death and inflammation occurring under a wide range of pathologic settings. The core event in necroptosis is the formation of the detergent-insoluble ‘necrosome’ complex of homologous Ser/Thr kinases, receptor protein interacting kinase 1 (RIPK1) and receptor interacting protein kinase 3 (RIPK3), which promotes phosphorylation of a key prodeath effector, mixed lineage kinase domain-like (MLKL), by RIPK3. Core necroptosis mediators are under multiple controls, which have been a subject of intense investigation. Additional, non-necroptotic functions of these factors, primarily in controlling apoptosis and inflammatory responses, have also begun to emerge. This review will provide an overview of the current understanding of the human disease relevance of this pathway, and potential therapeutic strategies, targeting necroptosis mediators in various pathologies.